SCAI

This channel contains news about the Society for Cardiac Angiography and Interventions (SCAI), including coverage of its annual meeting and links to recently released practice guidelines. SCAI is a leading resource in interventional cardiology and cath lab techniques and technologies. 
 

No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab

May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal ...

Home May 15, 2018
Home
News | Cath Lab

May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used ...

Home May 15, 2018
Home
A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018
Feature | Cardiovascular Clinical Studies

May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin ...

Home May 14, 2018
Home
A 3-D printed aortic root with an simulated implant of an Edwards Sapien TAVR valve. New clinical data points to length-of-stay as a new predictor of outcomes in TAVR patients. Image from Henry Ford Hospital.
Feature | Heart Valve Technology

May 14, 2018 – A new study finds patients who stay in the hospital for more than 72 hours when undergoing trans-femoral ...

Home May 14, 2018
Home
News | Chronic Total Occlusion (CTO)

May 14, 2018 – One-year outcomes of patients undergoing chronic total occlusion (CTO) percutaneous coronary intervention ...

Home May 14, 2018
Home
News | Peripheral Artery Disease (PAD)

May 14, 2018 — The Society for Cardiovascular Angiography and Interventions (SCAI) announced the launch of the SCAI PAD ...

Home May 14, 2018
Home
News | Chronic Total Occlusion (CTO)

May 14, 2018 — A significant update to the PROGRESS-CTO (PROspective Global Registry for the Study of Chronic Total ...

Home May 14, 2018
Home
News | Cardiovascular Clinical Studies

May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients ...

Home May 14, 2018
Home
Richard Schatz, M.D., (center) is research director of cardiovascular interventions at the Heart, Lung, and Vascular Center at Scripps Clinic, speaking at a SCAI session on collaboration with industry to bring new device technologies to market. He is best known as the co-inventor of the first coronary stent, the Palmaz-Schatz stent. Left is Ziyad Hijazi, M.D., MPH, director of the Sidra Cardiac Program. #SCAI, #SCAI2018
Feature | SCAI

Here is an aggregation of all the news and late-breaking studies presented at the 2018 Society for Cardiovascular ...

Home May 14, 2018
Home
News | Heart Valve Technology

May 11, 2018 — A new study looked at the effectiveness of a novel risk tool to predict 30-day readmission rates in ...

Home May 11, 2018
Home
News | Pulmonary Embolism

May 11, 2018 — Results of the FlowTriever Pulmonary Embolectomy (FLARE) study were presented as late-breaking clinical ...

Home May 11, 2018
Home
News

 


May 11, 2018 — Two studies examining seasonal variations in cardiac-related hospitalizations, specifically for ...

Home May 11, 2018
Home
News | Heart Valve Technology

May 11, 2018 — Medtronic plc announced two-year outcomes for the Harmony Transcatheter Pulmonary Valve (TPV) from its ea ...

Home May 11, 2018
Home
News | Structural Heart

May 11, 2018 — The post-approval study evaluating the safety and efficacy of MitraClip in a real-world, commercial ...

Home May 11, 2018
Home
News | Radiation Dose Management

May 10, 2018 — A new consensus document has been issued to guide the optimal use of ionizing radiation in cardiovascular ...

Home May 10, 2018
Home
Subscribe Now